Cargando…
Autosomal dominant polycystic kidney disease and pioglitazone for its therapy: a comprehensive review with an emphasis on the molecular pathogenesis and pharmacological aspects
Autosomal dominant polycystic kidney disease (ADPKD) is an inherited chronic kidney disorder (CKD) that is characterized by the development of numerous fluid-filled cysts in kidneys. It is caused either due to the mutations in the PKD1 or PKD2 gene that encodes polycystin-1 and polycystin-2, respect...
Autores principales: | Saini, Aryendu Kumar, Saini, Rakesh, Singh, Shubham |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731470/ https://www.ncbi.nlm.nih.gov/pubmed/33308138 http://dx.doi.org/10.1186/s10020-020-00246-3 |
Ejemplares similares
-
Drug repurposing in autosomal dominant polycystic kidney disease: back to the future with pioglitazone
por: Mao, Zhiguo, et al.
Publicado: (2021) -
Autosomal dominant polycystic kidney
por: Gudadhe, Rugaved Raghavendra, et al.
Publicado: (2022) -
Autosomal dominant polycystic kidney disease in Colombia
por: Camargo, Jessica T., et al.
Publicado: (2023) -
Dietary Aspects and Drug-Related Side Effects in Autosomal Dominant Polycystic Kidney Disease Progression
por: Quiroga, Borja, et al.
Publicado: (2022) -
Kidney volume and function in autosomal dominant polycystic kidney disease
por: Higashihara, Eiji, et al.
Publicado: (2013)